Home/Filings/4/0001628908-24-000092
4//SEC Filing

Rafferty Emily Ann 4

Accession 0001628908-24-000092

CIK 0001628908other

Filed

Aug 25, 8:00 PM ET

Accepted

Aug 26, 8:08 PM ET

Size

5.0 KB

Accession

0001628908-24-000092

Insider Transaction Report

Form 4
Period: 2024-08-22
Rafferty Emily Ann
Chief Operating Officer
Transactions
  • Sale

    Class A Common Stock

    2024-08-22$30.00/sh8,861$265,83063,408 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2024.
  • [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

Issuer

Evolent Health, Inc.

CIK 0001628908

Entity typeother

Related Parties

1
  • filerCIK 0001983577

Filing Metadata

Form type
4
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 8:08 PM ET
Size
5.0 KB